Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LGND > SEC Filings for LGND > Form 8-K on 19-Nov-2012All Recent SEC Filings

Show all filings for LIGAND PHARMACEUTICALS INC

Form 8-K for LIGAND PHARMACEUTICALS INC


19-Nov-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On November 19, 2012, Ligand Pharmaceuticals Incorporated ("Ligand" or the "Company") issued a press release entitled "Ligand Partner GlaxoSmithKline Receives FDA Approval for New Indication for PROMACTAŽ (eltrombopag)."

A copy of the press release, dated November 19, 2012, is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The contents of the press release are deemed to be filed for purposes of the Securities Exchange Act of 1934, as amended.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press release of the Company dated November 19, 2012.


  Add LGND to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LGND - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.